The Value factor has underperformed globally for the past 14 years, prompting some even to wonder if Value is ‘dead’. But, as our research shows, the factor’s behavior has varied starkly across equity markets and time.
More
US equity markets have continued their Q4 surge, with market watchers hoping for a traditional Santa Claus rally as we approach the end of a tumultuous year.
More
Seventeen fishermen are feared dead after a Russian fishing trawler capsized during a storm and sank in the freezing waters of the Arctic Ocean.
More
The head of Iran’s Red Crescent Society says the country will receive a shipment of coronavirus vaccines developed by Pfizer and BioNTech in three weeks.
More
Today, the European Commission adopted a package of €70 million under the Instrument for Pre-Accession (IPA II) to help fund the access of Western Balkans partners to COVID-19 vaccines procured by EU Member States.
More
An RFE/RL investigation shows the relatives of former Kazakh President Nursultan Nazarbaev have invested nearly $785 million in luxury properties in at least six countries over a 20-year time span.
More
Myovant and Pfizer to jointly develop and commercialize ORGOVYX™ (relugolix) and relugolix combination tablet and share profits and expenses in the U.S. and Canada
More
In Italy, a large proportion of patients with coronavirus disease 2019 (COVID-19) presented with symptoms (71.4% of 31 845 confirmed cases as of June 3, 2020). Common symptoms include cough, fever, dyspnea, musculoskeletal symptoms (myalgia, joint pain, fatigue), gastrointestinal symptoms, and anosmia/dysgeusia.
More
Children all over the world have had their education severely disrupted this year, as schools struggle to cope with repeated closures and re-openings, and the transition, if it’s even an option, to online schooling. Disadvantaged children, however, have been worst-hit by the emergency measures. In part three of our look back at the effect that
More